Search Results

1 - 10 of 408 items :

  • "Angiogenesis" x
Clear All
Evaluation of tumor angiogenesis in patients with non-small cell lung carcinoma

References 1. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. (2005). Global cancer statistics, 2002. CA: Cancer J Clin. 55, 74-108 2. Dudek, A.Z. & Mahaseth, H. (2005). Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Cancer Invest. 23, 193 - 200 3. Bremnes, R.M., Camps, C. & Sirera, R. (2006). Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumors and

Open access
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model

References 1. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997; 24(2): 235-258. 2 D’Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: Is the relationship resolved? Semin Reprod Med 2003; 21(2): 243-254. 3. Vinatier D, Orazi G, Cosson M, Dufour P. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2001; 96(1): 21-34. 4. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update. 2000; 6(1): 45

Open access
Angiogenesis and Non Small Cell Lung Cancer

References Gridelli C, Maione P, Rossi A, De Marinis F. The role of bevacizumab in the treatment of nonsmall cell lung cancer: current indications and future developments. Oncologist 2007; 12(10): 1183-1193. Dundar E, Oner U, Peker BC, Metintas M, Isiksoy S, Ak G. The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma. J Int Med Res 2008; 36(1): 88-95. Giaccone G. The potential of antiangiogenic therapy in non-small cell

Open access
Circulation Index as a Quantitative Indicator of Angiogenesis in Chorioallantoic Membrane of Chicken Broilers

REFERENCES AUSPRUNK DH, KNIGHTON DR, FOLKMAN J: Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol., 38: 237-248, 1974. BAUM O, SUTER F, GERBER B, TSCHANZ SA, BUERGY R, BLANK F, HLUSHCHUK R, DJONOV V: VEGF-A promote intussusceptive angiogenesis in the developing chicken chorioallantoic membrane. Microcirculation 7: 447–457, 2010. BURITY CHF, PISSINATTI A, MANDARIM-DE-LACERDA CA: Stereology of the Liver in Three Species of Leontopithecus (Lesson, 1840) Callitrichidae

Open access
The role of tumor-derived exosomes in tumor angiogenesis and tumor progression

References 1. Zaborowski MP, Balaj L, Breakefield XO, Lai CP. Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study. Bioscience . 2015;65(8):783-97. 2. Ribeiro MF, Zhu H, Millard RW, Fan GC. Exosomes Function in Pro- and Anti-Angiogenesis. Curr Angiogenes . 2013;2(1):54-9. 3. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998

Open access
Ovarian cancer: early detection, angiogenesis, lymphangiogenesis and current prospects for therapy

References 1. Czekierdowski A. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements. Ann Univ Mariae Curie Sklodowska Med. 2002;57:113-31. 2. Czekierdowski A, Smoleń A, Bednarek W, Kotarski J. Three dimensional sonography and 3D power angiography in differentiation of adnexal tumors. Ginekol Pol. 2002;73:1061-70. 3. Czekierdowski A, Szymański M, Szumiło J

Open access
The Importance of Vascular Endothelial Growth Factor as a Marker of Angiogenesis and Lymphangiogenesis in Non-small Cell Lung Cancer

angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182—1186. 8. Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer. 2006;41:143-158. 9. Hirakawa S, Kodama S, Kunstfeld R, et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphaticmetastasis. J ExpMed. 2005;201:1089–1099. 10. Kawai H, Minamiya Y, Ito M, et al. VEGF121 promotes lymphangiogenesis in the sentinel lymph nodes of non

Open access
Pharmacodynamics of julibroside J8 and J12 in inhibiting angiogenesis

References 1. Reynolds LP, Redmer DA. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. J Anim Sci. 1988; 76:1671-81. 2. Benn SI, Whitsitt JS, Broadley KN, Nanney LB, Perkins D, He L, Patel M, Morgan JR, Swain WF, Davidson JM. Particlemediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin. J Clin Invest. 1996; 98: 2894-902. 3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other

Open access
PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

mouse model correlates with Bcl-2 suppression and the inhibition of Akt kinase activity, Angiogenesis 15 (2012) 131-139; DOI: 10.10007/s10456-011-9248-7. 11. H. P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit and N. Ferrara, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation, J. Biol. Chem. 273 (1998) 30336-30343; DOI: 10.1074/jbc.273.46.30336. 12. K. T. Sabapathy, M. S. Pepper, F

Open access
Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways

cardiovascular development, Mol. Cell . 3 (1999) 403–414. 5. J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other diseases, Nat. Med . 1 (1995) 27–31; 6. S. R. Kumar, J. Singh, G. Xia, V. Krasnoperov, L. Hassanieh, E. J. Ley, J. Scehnet, N. G. Kumar, D. Hawes, M. F. Press, F. A. Weaver and P. S. Gill, Receptor tyrosine kinase EphB4 is a survival factor in breast cancer, Am. J. Pathol . 169 (2006) 279–293; 7. D. Yang, C. Jin, H. Ma, M. Huang, G. Shi, J. Wang

Open access